Multigene knockdown in Mycobacterium tuberculosis by repurposing the endogenous type III CRISPR system
通过重新利用内源 III 型 CRISPR 系统实现结核分枝杆菌多基因敲除
基本信息
- 批准号:9308467
- 负责人:
- 金额:$ 9.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-01 至 2018-12-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptive Immune SystemAnti-HIV AgentsCRISPR interferenceClinicalClustered Regularly Interspaced Short Palindromic RepeatsComplementary RNAEnzymesGene ChipsGene ExpressionGene Expression RegulationGene FamilyGene TargetingGenesGeneticGenetic TranscriptionGuide RNAMycobacterium tuberculosisOrganismPathogenesisPrecursor RNAProcessProteinsPublic HealthRNARNA PrecursorsRNA ProcessingRegulationResearchSelf-DirectionSeriesSpecific qualifier valueSystemTestingTimeToxinTranscriptTranscriptional RegulationTuberculosisbasedesigndrug developmentendonucleaseknock-downmembertooltranscriptome sequencing
项目摘要
ABSTRACT
The manipulation of gene expression in Mycobacterium tuberculosis (Mtb) remains a challenge. In particular
the regulation of multiple genes simultaneously is difficult and prohibitively time consuming. The CRISPR-Cas
system is an RNA-guided bacterial adaptive immune system with transformative potential for gene editing, and
CRISPR interference (CRISPRi), is a new tool to control gene expression in many organisms. CRISPR
systems are inherently multi-gene regulatory systems, based on their ability to express and process a CRISPR
array into many dozen RNAs that can each target a different gene. This unique multi-gene targeting function
has not yet been exploited because not all required precursor RNA processing components are known for
most systems, precluding their heterologous expression. However, these limitations apply only to the
orthogonal use of CRISPR systems when heterologous expression of all components is required. Endogenous
CRISPR systems, in contrast, provide all necessary components for processing and interference and are
optimally tuned to function in their particular host. Here, we will repurpose the endogenous Mtb type III
CRISPR system for the regulation of genes in any strain and for multi-gene regulation.
摘要
结核分枝杆菌(Mycobacterium tuberculosis,Mtb)的基因表达调控仍是一个挑战。特别是
同时调节多个基因是困难的,并且极其耗时。该CRISPR-Cas
系统是RNA引导的细菌适应性免疫系统,具有基因编辑的变革潜力,
CRISPR干扰(CRISPRi)是一种控制许多生物体中基因表达的新工具。CRISPR
CRISPR系统本质上是多基因调控系统,基于其表达和加工CRISPR的能力,
排列成几十个RNA,每个RNA可以靶向不同的基因。这种独特的多基因靶向功能
还没有被利用,因为不是所有需要的前体RNA加工组分都是已知的,
大多数系统,排除了它们的异源表达。但是,这些限制仅适用于
当需要所有组分的异源表达时,可以正交使用CRISPR系统。内源
相反,CRISPR系统提供了处理和干扰的所有必要组件,
最佳地调整以在其特定宿主中发挥作用。在这里,我们将重新利用内源性Mtb III型
CRISPR系统用于任何菌株中的基因调控和多基因调控。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christoph Grundner其他文献
Christoph Grundner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christoph Grundner', 18)}}的其他基金
Functional exploration of a deep Mycobacterium tuberculosis phosphoproteome
结核分枝杆菌深层磷酸蛋白质组的功能探索
- 批准号:
10656957 - 财政年份:2023
- 资助金额:
$ 9.8万 - 项目类别:
Direct activation of TGFbeta by an Mtb virulence factor to suppress CD4 T-cell responses
Mtb 毒力因子直接激活 TGFbeta 以抑制 CD4 T 细胞反应
- 批准号:
10374127 - 财政年份:2021
- 资助金额:
$ 9.8万 - 项目类别:
Direct activation of TGFbeta by an Mtb virulence factor to suppress CD4 T-cell responses
Mtb 毒力因子直接激活 TGFbeta 以抑制 CD4 T 细胞反应
- 批准号:
10191677 - 财政年份:2021
- 资助金额:
$ 9.8万 - 项目类别:
Functional phosphosignaling in Mtb infection
结核分枝杆菌感染中的功能性磷酸信号传导
- 批准号:
10177868 - 财政年份:2020
- 资助金额:
$ 9.8万 - 项目类别:
Functional phosphosignaling in Mtb infection
结核分枝杆菌感染中的功能性磷酸信号传导
- 批准号:
10040388 - 财政年份:2020
- 资助金额:
$ 9.8万 - 项目类别:
相似海外基金
Development of anti-HIV agents with dual mechanisms of actions based on triterpenoids as drug discovery templates
以三萜类化合物为药物发现模板,开发具有双重作用机制的抗 HIV 药物
- 批准号:
15K07998 - 财政年份:2015
- 资助金额:
$ 9.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of anti-HIV agents targeting weak points of viral replication mechanism
针对病毒复制机制的弱点开发抗HIV药物
- 批准号:
26670053 - 财政年份:2014
- 资助金额:
$ 9.8万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Structure activity and structure property relationships for novel anti-HIV agents
新型抗HIV药物的结构活性和结构性质关系
- 批准号:
8466077 - 财政年份:2012
- 资助金额:
$ 9.8万 - 项目类别:
Structure activity and structure property relationships for novel anti-HIV agents
新型抗HIV药物的结构活性和结构性质关系
- 批准号:
8777085 - 财政年份:2012
- 资助金额:
$ 9.8万 - 项目类别:
Development of anti-HIV agents that exert synergism with host immune pressure
开发与宿主免疫压力发挥协同作用的抗HIV药物
- 批准号:
24390254 - 财政年份:2012
- 资助金额:
$ 9.8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Design and synthesis of anti-HIV agents that inhibit the Pr55Gag membrane localization
抑制 Pr55Gag 膜定位的抗 HIV 药物的设计和合成
- 批准号:
24790124 - 财政年份:2012
- 资助金额:
$ 9.8万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Structure activity and structure property relationships for novel anti-HIV agents
新型抗HIV药物的结构活性和结构性质关系
- 批准号:
8588784 - 财政年份:2012
- 资助金额:
$ 9.8万 - 项目类别:
Developing host defense peptides as novel anti-HIV agents
开发宿主防御肽作为新型抗 HIV 药物
- 批准号:
230278 - 财政年份:2011
- 资助金额:
$ 9.8万 - 项目类别:
Fellowship Programs
Design and synthesis of anti-HIV agents that inhibit the Vif-mediated proteasome degradation of APOBEC3G
设计和合成抑制 Vif 介导的 APOBEC3G 蛋白酶体降解的抗 HIV 药物
- 批准号:
22659024 - 财政年份:2010
- 资助金额:
$ 9.8万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of anti-HIV agents using chemical genomics based on viral self-regulation mechanism
基于病毒自我调节机制的化学基因组学抗HIV药物的开发
- 批准号:
22659021 - 财政年份:2010
- 资助金额:
$ 9.8万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research














{{item.name}}会员




